TPM3 and CNN1

  • Number of citations of the paper that reports this interaction (PMID 2161834)
  • 66
  • Data Source:
  • HPRD (in vitro, in vivo)

TPM3

CNN1

Gene Name tropomyosin 3 calponin 1, basic, smooth muscle
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 41 interactors: ACTA1 ACTB BLOC1S6 C1orf216 CCDC102B CCDC114 CCDC146 CCHCR1 CNN1 FAM9C FBXO5 HDDC3 HSF2 IFIT3 IKBIP KCNE1 KIFC3 KXD1 LCA5L LURAP1 MAD1L1 MAGEA11 NEK2 OIP5 PBX3 S100A2 S100A4 SMAD3 SUMO4 SYCE1 TFPT THAP1 TLK1 TMOD1 TMOD2 TNNT1 TRAP1 TRIM27 TRIP6 VPS52 WASH3P 9 interactors: ACTA1 ADRB2 CALM1 DNMBP FYN MYO1A PRKCE TPM3 TUBB
Entrez ID 7170 1264
HPRD ID 01840 02884
Ensembl ID ENSG00000143549 ENSG00000130176
Uniprot IDs B4DQ80 P06753 Q5VU58 Q5VU63 Q8TCG3 B7Z7E1 P51911
PDB IDs 1WYP
Enriched GO Terms of Interacting Partners?
Tagcloud ?
aacr  accelerated  advancements  ago  approved  developments  discov  encodes  fda  fusions  harboring  next  ntrk1  oncd  oncogene  oncogenic  oncology  originally  precision  rationale  rearrangements  revisit  scientific  throughput  transforming  trk  trka  trkb  trkc 
actg2  adenomatous  archived  b4ganlt2  bank  casp3  cdx1  cdx2  classifier  col1a1  custom  ezr  fsp1  genomelab  hcellmarkerplex  house  hybridisation  incorporates  krt18  lgr5  ms4a12  muc2  mucin  nox1  ntn1  polyp  signatures  slc9a2  vwf 
Tagcloud (Difference) ?
aacr  accelerated  advancements  ago  approved  developments  discov  encodes  fda  fusions  harboring  next  ntrk1  oncd  oncogene  oncogenic  oncology  originally  precision  rationale  rearrangements  revisit  scientific  throughput  transforming  trk  trka  trkb  trkc 
actg2  adenomatous  archived  b4ganlt2  bank  casp3  cdx1  cdx2  classifier  col1a1  custom  ezr  fsp1  genomelab  hcellmarkerplex  house  hybridisation  incorporates  krt18  lgr5  ms4a12  muc2  mucin  nox1  ntn1  polyp  signatures  slc9a2  vwf 
Tagcloud (Intersection) ?